Protein phosphatase inhibition: structure based design. Towards new therapeutic agents.
about
Regulation of glioma cell migration by serine-phosphorylated P311Targeting protein serine/threonine phosphatases for drug developmentCrystal Structures of Protein Phosphatase-1 Bound to Nodularin-R and Tautomycin: A Novel Scaffold for Structure-based Drug Design of Serine/Threonine Phosphatase InhibitorsCharacterization of the tautomycin biosynthetic gene cluster from Streptomyces spiroverticillatus unveiling new insights into dialkylmaleic anhydride and polyketide biosynthesis.Characterization of the tautomycetin biosynthetic gene cluster from Streptomyces griseochromogenes provides new insight into dialkylmaleic anhydride biosynthesis.Comparison of cantharidin toxicity in breast cancer cells to two common chemotherapeuticsUtilization of the methoxymalonyl-acyl carrier protein biosynthesis locus for cloning of the tautomycin biosynthetic gene cluster from Streptomyces spiroverticillatus.Determinants for Substrate Specificity of Protein Phosphatase 2A.Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse.Use of okadaic acid to identify relevant phosphoepitopes in pathology: a focus on neurodegenerationCytotoxicity of a Series of Norcantharidin-Inspired Tetrahydroepoxyisoindole Carboxamides.New Norcantharidin Analogs: Synthesis and Anticancer Activity.Miklós Bodanszky Award Lecture: Advances in the selective targeting of protein phosphatase-1 and phosphatase-2A with peptides.PPP1R15A-mediated dephosphorylation of eIF2α is unaffected by Sephin1 or Guanabenz.Synthesis of Highly Selective Submicromolar Microcystin-Based Inhibitors of Protein Phosphatase (PP)2A over PP1.In-gel phosphatase assay using non-denaturing two-dimensional electrophoresis.Interrogating Protein Phosphatases with Chemical Activity Probes.From Spanish fly to room-temperature ionic liquids (RTILs): synthesis, thermal stability and inhibition of dynamin 1 GTPase by a novel class of RTILsChemoselective flow hydrogenation approaches to isoindole-7-carboxylic acids and 7-oxa-bicyclio[2.2.1]heptanes
P2860
Q24550884-14BA8DBB-43BD-4AF0-9E7B-07C578005629Q24658001-055F51DA-E049-4710-896E-6E0BD79B8752Q27652817-6137389F-6CDE-4DCA-BA4D-5D91A4652999Q33360680-23BA1527-7D1C-4A69-AD24-2056302DE279Q34255763-78AE88D3-DDBB-48D3-B647-6AA1D20054FBQ34267632-F4600D7D-FB6E-451E-8E14-851D874D7D32Q34696900-955A1C88-5971-4FEF-82D1-74010F2CC2EDQ35095669-F140E92A-EF37-4063-9C37-9D5525952403Q36698092-E7237F36-81F1-452B-82CE-9D2E64221F66Q36999161-4CBB5D9B-D5E6-4461-8F33-5569E94825DDQ38727476-A478FC20-5EC5-4003-BBFB-50366306165AQ38821108-45833968-4E92-4AD3-A9CA-B7E1CE4050E7Q40055940-21C2BD97-89D5-47DC-A5BB-DF94A79EA31EQ42058506-028EC543-16B1-4CEB-94E8-3A9DED9A6BA1Q42366758-135EE608-65B2-4AAC-BA21-479CD443182BQ48370408-43B61231-8DDF-42AC-8B4C-6103A735C1D5Q50026220-C2D64B2D-D1FB-4F61-938B-6E416813C80DQ57976231-D128DC27-4345-42F6-8742-D3BA4E7B2ADEQ58200374-53585A53-37C1-4728-8691-B8836D6530CD
P2860
Protein phosphatase inhibition: structure based design. Towards new therapeutic agents.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Protein phosphatase inhibition: structure based design. Towards new therapeutic agents.
@ast
Protein phosphatase inhibition: structure based design. Towards new therapeutic agents.
@en
type
label
Protein phosphatase inhibition: structure based design. Towards new therapeutic agents.
@ast
Protein phosphatase inhibition: structure based design. Towards new therapeutic agents.
@en
prefLabel
Protein phosphatase inhibition: structure based design. Towards new therapeutic agents.
@ast
Protein phosphatase inhibition: structure based design. Towards new therapeutic agents.
@en
P356
P1476
Protein phosphatase inhibition: structure based design. Towards new therapeutic agents.
@en
P304
P356
10.2174/1381612043452686
P577
2004-01-01T00:00:00Z